| A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance K Skivington, L Matthews, SA Simpson, P Craig, J Baird, JM Blazeby, ... bmj 374, 2021 | 2412 | 2021 |
| Developing core outcome sets for clinical trials: issues to consider PR Williamson, DG Altman, JM Blazeby, M Clarke, D Devane, E Gargon, ... Trials 13, 1-8, 2012 | 1512 | 2012 |
| The COMET handbook: version 1.0 PR Williamson, DG Altman, H Bagley, KL Barnes, JM Blazeby, ... Trials 18, 1-50, 2017 | 1474 | 2017 |
| Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer JL Donovan, FC Hamdy, JA Lane, M Mason, C Metcalfe, E Walsh, ... New England Journal of Medicine 375 (15), 1425-1437, 2016 | 1320 | 2016 |
| Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension M Calvert, J Blazeby, DG Altman, DA Revicki, D Moher, MD Brundage, ... Jama 309 (8), 814-822, 2013 | 1236 | 2013 |
| Guidelines for the management of oesophageal and gastric cancer WH Allum, JM Blazeby, SM Griffin, D Cunningham, JA Jankowski, ... Gut 60 (11), 1449-1472, 2011 | 707 | 2011 |
| The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care M Groenvold, MA Petersen, NK Aaronson, JI Arraras, JM Blazeby, ... european Journal of cancer 42 (1), 55-64, 2006 | 692 | 2006 |
| Challenges in evaluating surgical innovation PL Ergina, JA Cook, JM Blazeby, I Boutron, PA Clavien, BC Reeves, ... The Lancet 374 (9695), 1097-1104, 2009 | 679 | 2009 |
| Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial HER Ford, A Marshall, JA Bridgewater, T Janowitz, FY Coxon, J Wadsley, ... The lancet oncology 15 (1), 78-86, 2014 | 673 | 2014 |
| Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension M Calvert, D Kyte, R Mercieca-Bebber, A Slade, AW Chan, MT King, ... Jama 319 (5), 483-494, 2018 | 660 | 2018 |
| Core outcome Set-STAndards for development: the COS-STAD recommendations JJ Kirkham, K Davis, DG Altman, JM Blazeby, M Clarke, S Tunis, ... PLoS medicine 14 (11), e1002447, 2017 | 531 | 2017 |
| Core outcome set–STAndards for reporting: the COS-STAR statement JJ Kirkham, S Gorst, DG Altman, JM Blazeby, M Clarke, D Devane, ... PLoS medicine 13 (10), e1002148, 2016 | 486 | 2016 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 469* | 2021 |
| Randomized clinical trial comparing laparoscopic and open surgery for colorectal cancer within an enhanced recovery programme PM King, JM Blazeby, P Ewings, PJ Franks, RJ Longman, AH Kendrick, ... Journal of British Surgery 93 (3), 300-308, 2006 | 465 | 2006 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 437* | 2021 |
| Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer JM Blazeby, T Conroy, E Hammerlid, P Fayers, O Sezer, M Koller, ... European Journal of Cancer 39 (10), 1384-1394, 2003 | 436 | 2003 |
| Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial T Crosby, CN Hurt, S Falk, S Gollins, S Mukherjee, J Staffurth, R Ray, ... The lancet oncology 14 (7), 627-637, 2013 | 429 | 2013 |
| The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview MAG Sprangers, A Cull, M Groenvold, K Bjordal, J Blazeby, NK Aaronson Quality of Life Research 7, 291-300, 1998 | 417 | 1998 |
| Dressings for the prevention of surgical site infection JC Dumville, TA Gray, CJ Walter, CA Sharp, T Page, R Macefield, ... Cochrane Database of Systematic Reviews, 2016 | 398 | 2016 |
| Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer RN Whistance, T Conroy, W Chie, A Costantini, O Sezer, M Koller, ... European journal of cancer 45 (17), 3017-3026, 2009 | 389 | 2009 |
